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Studies on isolated pericytes have been hindered by the lack of specific
biochemical markers with which to facilitate identification and purification of
this cell type . The pericyte is defined by a strictly anatomical criterion in vivo,
namely its anatomical location within the microvascular basement membrane
and surrounding the endothelia (1). In dissociated cultures, pericytes have been
identified by morphological and growth characteristics (2-5). A recent study (6)
has shown that pericytes can be differentiated from endothelial cells and smooth
muscle cells by immunofluorescent staining with antibodies directed against actin
isoforms . Endothelial cells were shown to express only nonmuscle actin in stress
fibers, whereas smooth muscle cells expressed only muscle actin in stress fibers .
In contrast, pericytes were shown to express both muscle and nonmuscle actins
in stress fibers . The literature contains additional reports of differential distri-
bution of cytoplasmic and cytoskeletal/contractile proteins in vascular cell types
(7-9). However, while the differential distribution of cytoplasmic proteins allows
identification of vascular cells in vitro, antibodies to these proteins cannot be
used as selective agents for purifying cell types as the cells must be fixed and/or
permeabilized to make these antigens accessible to antibodies .
In this study we report the characterization ofanmAb (3G5) that appears to
be a specific marker for pericytes within the microvasculature . The 3G5 mAb
has previously been shown to react with brain cells, pancreatic islet cells, adrenal
medullary cells, thyroid follicular cells, renal glomerular cells, and peripheral
blood T lymphocytes (10, 11) . Nonetheless, within the microvasculature, the
3G5 mAb is a unique and useful pericyte marker and a selective agent for
enriching these cells .
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Materials and Methods
Retinal Cells.
￿
Retinal endothelial cells, retinal pigmented epithelial cells, and retinal
pericytes were harvested from calf retinal capillaries . Whole retinas were obtained by
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dissection of eyes obtained from a localslaughterhouse and treatment with 0.2% collagen-
ase (CooperBiomedical, Inc., Malvern, PA) in Earle's Balanced salt medium (Irvine
Scientific, SantaAna, CA) for 45 min . They were then homogenized and the homogenate
was passed over 210-, 88-, and 53-Wm meshes (Tetko, Elmsford, NY). The material caught
by the 53- and 88-,m meshes was collected and placed in human fibronectin (Collaborative
Research, Bedford, MA)-coated tissue culture dishes (Nunc, Roskilde, Denmark) with
Dulbecco's modification of Earle's Basal Medium (DMEM)' (Irvine Scientific) containing
1 % penicillin/streptomycin solution (Irvine Scientific). Initially, the growth of individual
cell types was selected using selective growth medium as described below.
Pericytes and Pigmented Epithelial Cells.
￿
The growth of retinal capillary pericytes and
retinal pigmented epithelial cells from explanted capillary fragments was selected for in
medium supplemented with .15% FCS (Gibco Laboratories, Grand Island, NY). Pigmented
epithelial cells were identified by electron microscopy and pericytes by morphology using
phase-contrast microscopy.
Retinal Endothelial Cells. The growth of retinal endothelial cells from explanted
microvessel fragments was selected for in medium supplemented with 10% plasma-derived
horse serum (HyClone Laboratories, Logan, UT), 90 ug/ml heparin (Sigma Chemical
Co., St. Louis, MO) and 120,ug/ml endothelial cell growth factor prepared from bovine
brain (12). The endothelial cells were identified by morphology and positive staining with
antibody to factor VIII .
Secondary Selection of Cells (Weeding Procedure).
￿
After 2-3 d in culture, the attached
cells were examined using phase-contrast microscopy and both desired cells and contam-
inating cells were identified by morphology. Contaminating cells were eliminated by
wiping the dish with a sterile cotton swab, followed by washing with calcium- and
magnesium-free PBS. This procedure was repeated daily until no contaminatingcells were
visible and the dishes were confluent.
Brain Cells.
￿
Rat brain microvessel pericytes were generously provided by Dr. M. P.
Carson (Boston University Medical School) and were isolated as previously described (13).
Endothelial Cells. Aorta were taken from newly slaughtered calves and the intimal
layer was treated with 0.25% collagenase for 20 min at 20°C. The released endothelial
cells were removed by wiping the intima gently with sterile cotton swabs twice. The swabs
were then placed in culture dishes and the endothelial cells were washed out and grown
in DMEM supplemented with 5% calf serum and 5% neonatal calf serum. The identity of
the endothelial cells was ascertained by cobblestone appearance on morphology. In
addition, the cells stained positive for factor VIII antigen and uptake of diacetylated low-
density lipoproteins (LDL).
Smooth Muscle Cells.
￿
Smooth muscle cells were obtained from the same aorta as the
endothelial cells. After removal of the intima, small pieces of the smooth muscle layer
(tunica media) were dissected out of the remaining aorta and used to initiate explant
cultures for smooth muscle cells. The cellswere maintained in DMEM supplemented with
10% FCS. After 2 wk in culture, explanted cells were recovered by trypsinization and
maintained in culture.
Coverslips.
￿
Plastic coverslips (VWR Scientific, Boston, MA) were sterilized with isopro-
pyl alcohol, rinsed with PBS, and coated with fibronectin before cells were added. All cell
types were recovered from culture dishes using 0.25% trypsin in 0.2% EDTA in PBS.
They were then grown on coverslips for 2-3 d before staining.
Fluorescence-activated Cell Sorting.
￿
Cells to be sorted or analyzed were trypsinized as
above and centrifuged for 5 min at 600 g. The cells were washed with DMEM supple-
mented with 10% FCS and resuspended in 1 .0 ml of 3G5 antibody diluted 1 :100 in
DMEM supplemented with 10% FCS and incubated at 4°C for 30 min before recentrif-
ugation. The pellet was washed twice with PBS and incubated for 30 min at 4°C with 1
ml of fluorescein-conjugated anti-mouse IgG antibody (Tago Inc., Burlingame, CA)
diluted 1 :20 in DMEM containing 10% FCS. The cells were then washed twice with 1
BSA (Fraction V; Sigma Chemical Co., St. Louis, MO) in PBS, and were resuspended in
I ml ofPBS and sorted or analyzed in an EPICS 752 flow cytometer (Coulter Electronics,
'Abbreviation used in this paper:
￿
DMEM, Dulbecco's modification of Earle's basal medium.NAYAK ET AL.
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Hialeah, FL). The 3G5+ and 3G5- fractionsobtained were plated in 35-mmdishes coated
with human fibronectin.
Monoclonal Antibodies.
￿
mAbs were produced as previously described (10, 14-16), and
prepared foruse as an ascites fluid from BALB/c mice. Ascites fluids generally contained
8-14 mg of Ig per ml.
Indirect Immunofluorescence.
￿
All reagents were diluted in PBS (pH 7.4) containing 1
BSA. mAbs were diluted 1:100 and fluorescein-conjugated goat anti-mouse IgG (heavy
and light chain) (Tago Inc.) was diluted 1:20.
Cells grown on coverslips were washed with PBS-1% BSA three times and incubated
with mAb at 20'C for 30 min in a humidified atmosphere. The coverslips were then
washed, and incubated with fluoresceinated anti-mouse IgG for 30 min at 20°C. The
coverslips were again washed (excess moisture removed by placingthe edge of the slip on
a paper tissue) andthen mounted onto a glass slide with AFT Systems mounting medium
(Calbiochem-BehringCorp., LaJolla, CA).The viable cells were then immediately viewed
on a Leitz dialux microscope equipped with both phase contrast and fluorescence optics.
Preparation of Rhesus Monkey Retinal Blood Vessels.
￿
Trypsinized retinal blood vessels
were prepared according to Kuwabara and Cogan (17). Briefly, rhesus monkey retinas
were fixed in 4% gluteraldehyde in PBS (pH 7.4) for 30 min at 4°C. The tissue was then
transferred to 10% formalin in PBS (pH 7.4) and stored for 1 mo at 4°C. Tissue was cut
into 0-5-cm' pieces and washed well with distilled water. The tissue pieces were then
placed in 3% trypsinin Tris-buffered saline (pH 7.8)at 37 0C for30-60 min. Thedigested
tissue wasthen transferred into water andthe neuronal cellswere shaken outof the tissue,
whichwas then transferred onto glass slides, air dried, andstained by indirect immunoflu-
orescence. Mounted retinal blood vessels prepared as described above were the generous
gifts of Mr. T. Schoen and Dr. T. Kuwabara, National Institutes of Health, Bethesda,
MD.
Identification of 3G5 Antigen of CapillaryPericytes.
￿
10 plates (100-mm diameter, -10'
cells) of cultured retinal capillary pericytes were harvested by trypsinization, washed in
PBS, and homogenized in 3 ml of distilled water. Glycolipids were extracted from the
homogenate by the method of Svennerholm and Fredman (18). Briefly, chloroform (C)
and methanol (M) were added to the homogenate to give a C/M/H20 ratio of 4:8:3 and
the mixture stirred for 30 min at 20 °C. The suspension was centrifuged at 2,000 g for
15 min and the resultant pellet was reextracted (as before). The supernatants were
combined and water added to give a C/M/H20 ratio of 1:2:1 .4, which caused a phase
partition. The upper methanol/water phase containing the glycolipids was collected and
dried by rotary evaporation. The residue was resuspended in C/M 2:1 and one-tenth of
the glycolipid extract was applied to each 1-cm lane of an aluminum-backed high-
performance thin-layer chromatography (HPTLC) plate (E. M. Science, Cherry Hill, NJ).
TheTLCplatewasdevelopedin an ascendingsolventsystem ofC/M/0.25% KCl(aqueous)
5:4:1 . When thesolvent front reachedthe top ofthe plate, theplate was removed and air
dried. The lanes of the TLC plate were cut out of the plate, coated with a saturated
solution of polyisobutyl methacrylate in hexane (90-simmersion) and airdried. Theplates
were then immunostained using a modification of the method of Magnani et al. (19).
Briefly, the TLC strips were blocked by immersion in PBS containing 3% BSA for 1 h.
The lanes were then incubated with either mAb 3G5 or control antibody P3X63 Ag8 at
a 1:100 dilution in PBS-3% BSA for 2 h. The strips were washed three times in PBS-3%
BSA and then incubated with peroxidase-conjugated rabbit anti-mouse Ig (1 :100) (Dako
Corp., Santa Barbara, CA). The strips were washed again and then incubated with
peroxidase-conjugated swine anti-rabbit Ig (1 :100) (Dako Corp.). The color reaction was
initiated by addition of 40 mg of 4-chloro-l-napthol in 50 ml of 50 mM Tris, pH 7.4,
containing 0.012% H202. The mobility of the immunostained band was compared with
the mobilities ofauthentic ganglioside markers purified from bovine brain (Bachem, Inc.,
Torrance, CA).1006
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FIGURE 1 .
￿
Immunofluorescent stain of vascular cells in vitro . (a) Phase-contrast micrograph
of bovine retinal pericytes ; (b) mAb 3G5 staining of the same field shown in (a) ; (c) Phase-
contrast micrograph of retinal endothelial cells; (d)mAb3G5 staining of the same field shown
in (c). Scale bar = 10 km .
Results
Immunostaining of Cells Grown on Coverslips .
￿
A panel of mAbs initially col-
lected for their reactivity with pancreatic islet cells, were screened by indirect
immunofluorescence for crossreactivity with bovine retinal pericytes. Nine mAbs
were screened and only two, 3G5 and HISL-8, were seen to specifically bind to
the cell surface of cultured pericytes (in comparison with the control myeloma
protein P3X63.Ag8). ThemAb 3G5 was selected for further study as the HISL-
8 hybridoma line reverted to a nonproducing phenotype. The appearance of
3G5 immunofluorescent staining of bovine retinal capillary pericytes and bovine
retinal endothelial cells is shown in Fig . 1 . Panel a shows the appearance of
pericytes grown on coverslips under phase contrast optics and panel b is the same
field immunofluorescently stained with 3G5. The cells in a and b showed
morphology and growth kinetics typical of pericytes, i .e ., they grew very slowly,
formed overlapping monolayers at confluence (not shown), and appeared to be
large flattened cells which often had dendritic processes (as can be seen in Fig .
1, a and b) . In comparison, mAb 3G5 did not stain bovine retinal endothelial
cells (Fig . 1, c and d) . These endothelial cells do stain positively with diacetylated
LDL and anti-factor VIII antibodies and do have a typical cobblestone appear-
ancewhen confluent(not shown) . These studies were performed on subconfluentNAYAK ET AL .
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TABLE I
Summary ofmAb 3G5 Binding to Various Vascular Cell Types
Cell types
￿
3G5 binding*
* +, Stained cells observed ; -, no stained cells observed.
P3X63.Ag8
binding
cultures, as confluent cell cultures tended to wash off the coverslips as a sheet
(particularly smooth muscle and endothelial cells) . The resultsof immunostaining
cells grown on coverslips are shown in Table I . As shown above, bovine retinal
capillary pericytes were positively stained with mAb 3G5 . Rat brain capillary
pericytes were also found to be positively stained with mAb 3G5 . In contrast,
bovine retinal endothelial cells, aortic endothelial cells, retinal pigment endothe-
lial cells, and aortic smooth muscle cells were all negative for 3G5 . All cells were
negative for staining with control myeloma protein P3X63.Ag8 .
Fluorescence-activated Cell Sortingand Analysis.
￿
Trypsinized cells in suspension
were stained by indirect immunofluorescence using mAb 3G5 and control
myeloma protein P3X63.Ag8 . The stained cell suspensions were analyzed by
FACS (Fig . 2) . The 3G5+ cells of pericyte cultures are seen as a broad peak
encompassing a large range of fluorescence intensity with a sharp initial peak of
negative cells (Fig . 2a) . Fig . 2, b, c, and d, show the staining profile ofmAb 3G5
on bovine retinal pigmented endothelial cells, bovine retinal endothelial cells,
and bovine aortic smooth muscle cells, respectively . Each of these three cell types
gave a sharp peak of little or no fluorescence intensity with mAb 3G5, which in
each case represented negative staining as the 3G5 stain was identical to the
P3X63.Ag8 control staining (not shown) . In some cultures of smooth muscle
cells a small proportion (-5%) of the cells stained positively with 3G5, probably
reflecting contamination with aortic intimal cells which we have found to be
3G5+ (our unpublished observation) . These results obtained by FACS confirm
the fluorescence microscopy results showing specific 3G5 staining of pericytes .
These results also suggest that selection of intensely 3G5+ cells from retinal
microvascular cell cultures will effectively purify pericytes . To evaluate the utility
of mAb 3G5 as a means of purifying pericytes, retinal pigmented endothelial
cells and retinal capillary pericytes were mixed in a ratio of9 :1, respectively, and
cocultured . The mixed culture was then trypsinized, fluorescently labeled with
mAb 3G5, and sorted with aFACS . Cells were collected in two fractions ; one of
high fluorescence intensity and one representing all the remaining cells . The two
Bovine retinal
capillary pericyte +
Rat brain
capillary pericyte +
Bovine retinal
endothelial cells -
Bovine retinal
pigment epithelial cells -
Bovine aortic
smooth muscle cells -
Bovine aortic
endothelial cells -1008
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FIGURE 2 .
￿
Fluorescence-activated flow cytometry of mAb 3G5-stained vascular cells . (a)
Bovine retinal pericytes ; (b) Bovine retinal pigmented epithelial cells ; (c) Bovine retinal
endothelial cells ; (d) Bovine smooth muscle cells.
fractions were plated and cultured for 1 wk, and the high fluorescence intensity
culture was reanalyzed for 3G5 staining by FACS . The large majority of cells in
the mixed culture were negative, with only a small tail of 3G5+ cells evident
(representing -8% positive cells, Fig. 3a). The reanalysis of cells selected for by
3G5 staining and sorting is shown in Fig. 3b . The shape of the peak is very
similar to that seen previously with 3G5-stained pericyte cultures ; furthermore,
quantitation indicates that >70% of cellsexpressed the 3G5 antigen as compared
with ^-8% indicating a greater than nine-fold enrichment over the level in the
mixed coculture .
mAb 3G5 Staining ofRetinal Capillaries In Vivo .
￿
The 3G5 staining pattern on
retinal capillaries prepared from the rhesus monkeys is shown in Fig. 4a . The
fluorescence was limited to the external margins of the capillary walls and
numerous protrusions of the capillaryexternal margins were seen to be intensely
stained. This intense staining of protrusions of the capillary external margin is
consistent with staining of capillary pericytes in vivo . Furthermore, the staining
of the capillary external margin was continuous, as would be expected from the
known 1 :1 distribution of pericytes to endothelial cells in retinal capillaries (20) .
Control staining with the P3X63.Ag8 myeloma protein is shown in Fig . 4b .
Weak, diffuse fluorescence is associated with the microvessels after controlZ
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W
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FIGURE 3.
￿
Enrichment of 3G5* cells from mixed retinal cell culture by FACS. (a) Cell sorter
analysis of 9:1 mixture of retinal pigmented epithelial cells/retinal pericytes; immunofluores-
cently stained with mAb 3G5. (b) Cell sorter analysis of 3G5+ cells selected from a; grown in
tissue culture, and restained with mAb 3G5 before reanalysis.
staining. Control antibody-stained preparations showed more intense, but diffuse
staining of erythrocytes within the microvessels. Attempts to stain the endothe-
lium with antibodies to factor VIII gave identical staining to that seen with
P3X63.Ag8 antibodies, presumably due to denaturation of factor VIII antigen
by glutaraldehyde fixation and/or trypsinization.
Identification of the 3G5 Antigen of Retinal Pericytes.
￿
The 3G5 antigen of
cultured pericytes migrated on TLC as a single band below the GM2 ganglioside
marker and above the GM 1 ganglioside marker (Fig. 5, lane 2). In contrast, no
band was seen in the lane incubated with the P3X63.Ag8 myeloma protein (Fig.
5, lane 1). The pericytes 3G5 antigen has the same migration on TLC as the
antigen found in pancreas and T lymphocytes (11, 21) and comigrates with one
of several 3G5 antigens found in brain extracts (21).
Discussion
An mAb (3G5) to pancreatic islet cells, which crossreacts with bovine retinal
capillary pericytes, has been identified by staining the cell surface of viable
pericytes using indirect immunofluorescence. The staining is specific for peri-
cytes, within the context of the microvasculature, as the antibody did not
detectably bind to endothelial cells, retinal pigmented epithelial cells, or aortic
medial smooth muscle cells. Furthermore, mAb 3G5 stained retinal capillaries
in vivo with a fluorescence distribution consistent with pericyte staining. The
prominent staining of protrusions of the capillary wall is similar to the description
of pericyte staining in periodic acid Schiff (PAS)-stained capillary preparations
of the retina (22), and the apparently continuousstaining of the external capillary
wall may be expected in view of the recent report of extensive pericyte coverage
of the endothelial cell tube in retinal capillaries (23). The pattern of staining
observed with mAb 3G5 is due to specific binding of the antibody, as similar
staining could not be obtained using the control antibody P3X63 .Ag8. Attempts
to stain these preparations with antibodies to factor VIII (not shown) gave the
same diffuse nonspecific staining pattern observed with P3X63.Ag8 myeloma1010
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FIGURE 4.
￿
mAb 3G5 staining of retinal
microvessels in vivo . (a) Distribution of
mAb 3G5 stain on trypsin-digested prep-
arations of rhesus monkey retinal micro-
vessels . Arrows indicate stained protru-
sions consistent with binding to pericytes .
Scale bar = 10 Am . (b) Control
(P3Xfi3.Ag8 myeloma protein) staining
on trypsin-digested preparations ofrhesus
monkey retinal microvessels arrow indi-
cates putative pericyte .
protein . As these retinal microvessel preparations are fixed with glutaraldehyde
and trypsinized to release the neurons that obscure the vessels, the factor VI11
antigen and other glutaraldehyde/trypsin-sensitive protein antigens will have
been destroyed, thus explaining the absence of specific anti-factor VIII staining.
The 3G5 antigen, however, is not a protein and is therefore glutaralde-
hyde/trypsin-resistant and consequently maintained in these preparations . The
pericyte 3G5 antigen was demonstrated to be a glycolipid antigen that migrates
between GM2 and GM 1 gangliosides on TLC. This antigen is insensitive to the
action of trypsin and, therefore, the mAb was used to stain viable trypsinizedNAYAK ET AL .
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FIGURE 5 .
￿
Identification of the 3G5 antigen of tissue-cultured bovine
retinal pericytes . (Lane 1) Pericyte glycolipid extract chromatographed by
TLC and stained with P3X63.Ag8 myeloma protein ; (lane 2) pericyte
glycolipid extract chromatographed by TLC and stained with mAb3G5 .
The position of authentic ganglioside markers is shown to the right of
lane 2 . The ganglioside nomenclature is that of Svennerholm (39) .
cells. The mAb 3G5 was seen to stain pericyte cultures with a broad range of
fluorescence intensity, which at its lowest overlaps the profile of negative cells.
These 3G5- pericytes are, as yet, otherwise unidentified but are most probably
contaminatingnegative cells, as itwould be expected to take more than onecycle
of cell sorting to purify a cell type to homogeneity. Another possible factor that
may explain the presence of 3G5- pericytes is the possible downregulation of
antigen expression during particular stages of the cell cycle . We are currently
investigating the possible cell cycle regulation of 3G5 antigen in microvascular
pericytes . These results indicate that mAb 3G5 may be a useful marker of
microvascular pericytes . However, we have only, thus far, studied pericytes from
central nervous system tissue . Consequently it remains to be ascertained whether
this antibody will specifically stain microvascular pericytes of extraneural tissues .
Nonetheless, using immunofluorescently stainedtrypsinized cells, we have shown
that mAb 3G5 can be effectively used to selectively enrich pericytes from a
mixed population of retinal cells using aFACS . We have not as yet attempted to
enrich pericytes from mixtures with endothelial cells; however, as endothelial
cells may be expected to be the major contaminant of pericyte cultures, cell
sorting with mAb 3G5 may be of greatest use in this context . This antibody may
also be'of use in depleting pericytes from vascular cell cultures by complement-
mediated cytotoxicity, as it is an IgM class antibody and consequently fixes
complement, or alternatively, by theproduction ofmAb 3G5-conjugated toxins .
The embryonic origin of pericytes remains essentially unknown, although it
has been suggested that mesenchyme-derived cells form the pericytes of capillar-
iesin amphibian larvae (24). This conclusion wasbasedon continuous observation
of cellular migration in the translucent tails of tadpoles . Investigations using
biochemical markers in studies of development of capillary pericytes have not
been reported . The availability ofmAbs will enable immunohistochemical studies
to further define the embryonic origin of pericytes and their differentiation
program. It has been suggested that the pericyte is a relatively undifferentiated
cell type that has pluripotential properties . Pericyte pluripotentiality has been
suggested on the basis of expression of both muscle and nonmuscle actins (6)
and the observation that a small population of infantile hemangiopericytoma
cells appear to transform into cell types other than pericytes (25) . The tissue
distribution of the 3G5 antigen outside of the vascular system suggests that mAb1012
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3G5 may be considered as a neuroendocrine cell marker (10), although it does
react with nonneuroendocrine cell types as well (11). The 3G5-reactive cells
include cells of the brain, pancreatic islet cells, adrenal medullary cells, thyroid
follicular cells, renal glomerular cells, and T-lymphocytes. Clearly the 3G5
antigen is expressed on terminally differentiated cell types and is probably a
differentiation antigen of the "jumping type" as defined by Springer (26). The
relationship of pericytes to smooth muscle cells is also brought into question, as
pericytes have been shown to express muscle type contractile proteins but the
3G5 antigen is not found on either smooth or skeletal muscle (10). Further
studies pursuing our observation (unpublished) that aortic intimal cells, but not
medial cells, express the 3G5 antigen may enable the question ofthe relationship
of smooth muscle cells to pericytes to be addressed more fully, as the pericyte
has been considered by some authors to be similar to the so called "myointimal
cell" (27) and the intermediate cell ofRobertson (28) and Page et al. (29). These
cells were considered to be dedifferentiated smooth muscle cells or to be derived
by growth from smooth muscle cells ofthe tunica media (1). These studies may
be of some functional significance, as the pericyte has been reported to have
contractile capabilities and thus a role in capillary contraction (30). This, how-
ever, remains a controversial conclusion.
The 3G5 antigen of pericytes was found to be a glycolipid of mobility
intermediate between the ganglioside markers GM2 and GM1. This mobility is
identical to that observed ofboth the Tlymphocyte (11) and pancreatic islet cell
antigen (21). In the brain, however, mAb 3G5 binds to at least five glycolipid
bands on TLC including the high-mobility band found in pancreatic islets,
pericytes, and T lymphocytes(21). The available evidence indicatesthat multiple
forms ofthe 3G5 antigen exist only in the brain and that the high-mobility 3G5
antigen ofbrain is expressed in extraneural tissue. Clearly then, the expression
of the 3G5 epitope is differentially regulated, suggesting that a more complex
pattern of expression of enzymes involved in the biosynthesis of the 3G5
glycolipid antigen exists in the brain than in extraneural tissues. The function of
the 3G5 antigen is unknown, but gangliosides have been shown to have roles in
cellular recognition and as onco-developmental antigens (31), as modulators of
receptor phosphorylation (32), and as targets of autoimmunity (21, 33, 34).
Furthermore, a ganglioside of similar mobility has been shown to be distributed
in a dorso-ventral gradient in the developing rat retina, suggesting a role in the
establishment of visual system topography (35).
The 3G5 mAb may also be of use in facilitating the unambiguous demonstra-
tion and quantitation of pericyte loss reported to occur in both human and
canine diabetes (20, 36-38) through development ofdouble-staining procedures
using mAb 3G5 and anti-endothelial cell antibodies. This approach may also
enable accurate quantitation ofendothelial cell/pericyteratios in variouscapillary
beds.
In conclusion, mAb 3G5 is potentially an excellent tool for studying both the
differentiation and function of microvascular pericytes, and the functional role
of the 3G5 cell surface ganglioside.NAYAK ET AL.
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Summary
The identification of microvascular pericytes in vitro relies principally on
morphological characteristics and growth dynamics, as there is a paucity of
immunochemical markers for these cells. Consequently, an attempt was made to
identify mAb reagents that would aid in both the rapid identification and
enrichment of retinal capillary pericytes in vascular cell cultures.
A panel of mAbs raised by xenogeneic immunization of mice with various
tissues was screened for immunoreactivity with dissociated cultures of bovine
retinal capillary pericytes. Two antibodies from the panel (3G5 and HISL-8)
were seen to react with pericytes by indirect immunofluorescence. The mAb
3G5 was selected for further study. mAb 3G5 did not react with dissociated
cultures ofsmooth muscle cells, endothelialcells, or retinalpigmentedendothelial
cells. The pericyte 3G5 antigen was insensitive to theaction of trypsin; therefore,
mAb 3G5 was used to selectively purify pericytes from trypsinized mixed retinal
cell cultures by flow cytometry. 3G5+ pericytes (representing 8% of cells in a
mixed retinal cell culture) were enriched at least nine-fold to represent >70% of
cells. The mAb 3G5 stained retinal capillaries in vivo with a fluorescence
distribution consistent with pericyte staining. The 3G5 antigen of cultured
pericytes was found to be a glycolipid of mobility intermediate between ganglio-
side markers GM 1 and GM2.
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